BackMedline Overview

Medline EBIT

Track Medline's EBIT ($1.8B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$403.00M
↓ 31.93% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

$1.82B

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin

Medline (MDLN) FAQ

As of the most recent data (June 2026), MDLN shows a EBIT of $1.8B. That is above the sector sector average of $-6.4M. Scroll down for historical charts and peer comparison views.

The its sector sector average EBIT is about $-6.4M. Medline is at $1.8B, which is higher that average. That is roughly 28574.4% above the sector mean. Use the comparison chart on this page to see how MDLN stacks up against individual peers as well.

Tracking MDLN's ebit over time shows whether Medline is scaling, shrinking, or reshaping that part of the business. The current reading is $1.8B Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Medline's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $1.8B) with ownership activity and broader fundamentals.